Amylyx Pharmaceuticals, Inc. (AMLX)
Since Mar 31, 2022, Amylyx Pharmaceuticals, Inc. (AMLX) has reported earnings 18 times. On average the shares move ±7.23% post-earnings, with a positive reaction 38.9% of the time. Its largest post-earnings gain was +21.1% (Feb 22, 2024) and its largest decline was -31.89% (Nov 09, 2023). The next earnings report is predicted for 2026-08-07 (approximate).
Earnings reactions
How AMLX moved on each past earnings report.
Earnings Impact
Total Earnings
18
Avg Abs. Movement
±7.23%
Positive %
38.9%
Negative %
61.1%
Historical Earnings Statistics
| Date | Timing | Earnings move | SEC Filing |
|---|---|---|---|
| May 07, 2026 | ☀ PRE | -5.2% | open_in_new |
| Mar 03, 2026 | ☀ PRE | -7.78% | open_in_new |
| Nov 06, 2025 | ☀ PRE | -5.89% | open_in_new |
| Aug 07, 2025 | ☀ PRE | -4.27% | open_in_new |
Earnings Count
18
Total earnings in dataset
Avg Abs. Movement
±7.23%
Avg % price change on earnings
Institutional ownership
Holdings as of Mar 31, 2026 · SEC 13-F
SEC Filing Types
Recent SEC Filings
10 most recent| Form | Date Filed | View on EDGAR |
|---|---|---|
| 4 | 20260713 | open_in_new SEC.gov |
| 144 | 20260709 | open_in_new SEC.gov |
| 4 | 20260608 | open_in_new SEC.gov |
| 4 | 20260608 | open_in_new SEC.gov |
| 4 | 20260608 | open_in_new SEC.gov |
| 4 | 20260608 | open_in_new SEC.gov |
| 4 | 20260608 | open_in_new SEC.gov |
| 8-K | 20260604 | open_in_new SEC.gov |
| 4 | 20260526 | open_in_new SEC.gov |
| SCHEDULE 13G/A | 20260515 | open_in_new SEC.gov |
Frequently asked about AMLX earnings
When does Amylyx Pharmaceuticals, Inc. report earnings next? expand_more
Amylyx Pharmaceuticals, Inc. (AMLX)'s next earnings date is approximate for 2026-08-07. This is a prediction based on its historical quarterly reporting pattern, not a company-confirmed date.
How much does AMLX stock move after earnings? expand_more
Over 18 reports, AMLX has moved an average of ±7.23% the session after earnings, closing higher 38.9% of the time.
What was AMLX's biggest post-earnings move? expand_more
AMLX's largest post-earnings gain on record was +21.1% on Feb 22, 2024, and its largest decline was -31.89% on Nov 09, 2023.
Where can I find Amylyx Pharmaceuticals, Inc.'s SEC filings? expand_more
All of Amylyx Pharmaceuticals, Inc.'s SEC filings — 10-K, 10-Q, 8-K and more — are listed in the SEC filings section on this page, each linking to the original document on SEC.gov.
Sector peers
- Aardvark Therapeutics, Inc. (AARD) earnings history chevron_right
- AbCellera Biologics Inc. Common Shares (ABCL) earnings history chevron_right
- ABEONA THERAPEUTICS INC. (ABEO) earnings history chevron_right
- Acumen Pharmaceuticals, Inc. Common Stock (ABOS) earnings history chevron_right
- Arbutus Biopharma Corp (ABUS) earnings history chevron_right
- ABVC BioPharma, Inc. Common Stock (ABVC) earnings history chevron_right
- ACADIA PHARMACEUTICALS INC (ACAD) earnings history chevron_right
- Adicet Bio, Inc. Common Stock (ACET) earnings history chevron_right
- Acadia Healthcare Company, Inc. Common Stock (ACHC) earnings history chevron_right
- Achieve Life Sciences, Inc. Common Shares (ACHV) earnings history chevron_right
Reporting around the same time
- ALAMO GROUP INC (ALG) earnings 2026-08-04
- Aligos Therapeutics, Inc. Common Stock (ALGS) earnings 2026-08-05
- AbCellera Biologics Inc. Common Shares (ABCL) earnings 2026-08-05
- Airbnb (ABNB) earnings 2026-08-05
- Arcosa, Inc. (ACA) earnings 2026-08-04
- ACADIA PHARMACEUTICALS INC (ACAD) earnings 2026-08-05
- ACCO BRANDS Corp (ACCO) earnings 2026-08-04
- ProFrac Holding Corp. (ACDC) earnings 2026-08-07